It is time to consider third-line options in antiretroviral-experienced paediatric patients?

BACKGROUND: The historic use of full-dose ritonavir as part of an unboosted protease inhibitor (PI)-based antiretroviral therapy regimen in some South African children contributes to the frequent accumulation of major PI resistance mutations. METHODS: In order to describe the prevalence of major PI...

Descripción completa

Detalles Bibliográficos
Autores principales: van Zyl, Gert U, Rabie, Helena, Nuttall, James J, Cotton, Mark F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228719/
https://www.ncbi.nlm.nih.gov/pubmed/22085598
http://dx.doi.org/10.1186/1758-2652-14-55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228719/
https://www.ncbi.nlm.nih.gov/pubmed/22085598
http://dx.doi.org/10.1186/1758-2652-14-55

Ejemplares similares